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Abstract
Introduction: On the basis of the recently recognized potential of hematopoietic stem cells (HSCs) to give rise to
hepatocytes, we have assessed the potential of granulocyte colony-stimulating factor (G-CSF)-mobilized bone
marrow-derived CD34
+ HSCs to contribute to faster recovery and promote regeneration process after acute liver
injury by radiation.
Methods: G-CSF-mobilized CD34
+ HSCs (1 × 10
5 cells per mouse) were injected via tail vein in the irradiated femal
nonobese diabetic/severe combined immunodeficient mice. Irradiated control animals received only saline infusion.
Results: The mobilized CD34
+ HSCs significantly ameliorated radiation-induced liver damage. In the liver of
recipient mice killed 21 days after irradiation, human albumin
+ Y-chromosome
+ hepatocyte-like cells, or human
cytokeratin
+ Y-chromosome
+ hepatocyte-like cells formed cords of hepatocytes, occupied ~30% of the 4-μm
section surrounding portal tracts. Furthermore, human-specific albumin mRNA expressed in the liver and human
albumin was detected in the serum only in the CD34
+ HSC-treated mice.
Conclusions: Treatment with G-CSF-mobilized CD34
+ HSCs from bone marrow into peripheral blood could
significantly promote tissue reparation after acute liver injury by radiation in mice, possibly by the ability of CD34
+
HSCs to generate hepatocytes. So mobilization of CD34
+ HSCs might offer a novel therapeutic approach for the
treatment of radiation-induced complications after radiotherapy or other acute liver diseases in humans.
Introduction
During radiotherapy, the most important dose-limiting
factor is sensitivity of the normal tissue lying in the
radiation field. Even with the most optimal radiation
schedule, damage still occurs in normal tissues.
Clinically, radiotherapy has played a limited role in the
treatment of malignant intrahepatic cancers owing to
the low tolerance of liver to radiotherapy. Radiation-
induced liver damage had been observed in 5-10% of
patients, who had received radiation doses exceeding 30
Gy [1,2]. In addition, liver transplantation is the only
current therapeutic modality for liver failure, but owing
to the shortage of organ donors, it is available to only a
small proportion of patients .A d u l ts t e mcell therapy
could solve the problem of degenerative disorders,
including liver disease, in which organ transplantation is
inappropriate or there is a shortage of organ donors.
This view is predicated upon the evidence that stem
cells, particularly those in hematopoietic tissue, have the
ability to develop into endodermal, mesodermal, and
ectodermal cell types [3].
Hematopoietic stem cells (HSCs) have been used for
hematological reconstitution for many years. Recently,
however, homing and engraftment of HSCs in damaged
nonhematopoietic organs, such as vascular tissue [4],
myocardium [5-9], brain [10,11], liver [12-14], kidney
[15], lung [16,17], skin [17], and salivary glands [18]
have been observed and were suggested to contribute to
the wound-healing process. In some tissues such as
myocardium [6,8,9,19] and liver [12], even improved
function has been observed. These studies have provided
the proof of principle of damage repair by the applica-
tion of HSCs. A clinically attractive approach is to use
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lize HSCs to the circulation, and it has been reported
that G-CSF administration after partial orthotopic liver
transplantation greatly improved survival rate and liver
regeneration of partial graft, partly by its mobilizing
HSCs into the injured liver to differentiate into hepato-
cytes through hepatic oval cell engraftment. However,
the role of G-CSF-mobilized HSCs in the regeneration
of radiation-induced liver injury is unknown and is less
understood for this process.
In the current study, we investigated the possibility
that G-CSF-mobilized CD34
+ HSCs could home to the
injured liver and promote tissue repair. We also primar-
ily examined the origin of cells reconstituting liver after
acute injury by radiation in mice.
Materials and methods
Animals
Six- to 8-week-old female nonobese diabetic/severe
combined immunodeficient (NOD/SCID) mice were
purchased from the Animal Breeding Center of the Pek-
ing University (Beijing, China). All mice were bred and
maintained under defined flora conditions in individu-
ally ventilated (high-efficiency particle-arresting filtered
air) sterile microisolator cages (Techniplast, Milan,
Italy). All animal handling and experimental procedures
were approved by the Animal Care and Use Committee
of Zhengzhou University.
Isolation of human HSCs
G-CSF-mobilized peripheral blood cells were obtained
from leukaphereses processed by using a continuous flow
cell separator Fenwal CS 3000 (Baxter, Deerfield, IL,
USA). Informed consent and local research ethics commit-
tee approval were granted in all cases. After the mononuc-
lear cell fraction was collected, CD34
+ cells were isolated
using the CD34
+ positive cell selection kit (MiniMacs;
Miltenyi Biotec, Bergisch Gladbach, Germany).
Radiation-induced liver damage and G-CSF-mobilized
CD34
+ HSCs administration
Female NOD/SCID mice were randomly divided into
three groups (n = 20 in each group). Animals in
Groups 1 and 2 were anesthetized using injection of
ketamine (Yuhan Co., Seoul, Korea; 50 mg/kg, i.p.) and
xylazine (Bayer, Ansan, Korea; 5 mg/kg, i.p.) prior to
immobilization in the recumbent position on a treat-
ment table. The liver portion was centered in a 2 × 4-
cm exposure field with the other abdomen, and the
body was protected using customized lead shielding.
Then the mice were subjected to a single dose of irra-
diation of 260 cGy with a cesium source (MDS Nor-
dion; Gammacell, Ottawa, ON, Canada). After this, G-
CSF-mobilized human CD34
+ cells (1 × 10
5 cells per
mouse) were injected via tail vein in Group 1 (G1)
immediately after irradiation. Animals in Group 2 (G2)
received the same volume of saline and served as con-
trols. Mice in Group 3 (G3) served as normal controls.
After 7 or 21 days to irradiation, mice were killed
under anesthesia. The left lobe of the liver was fixed in
4% paraformaldehyde and paraffin-embedded for sec-
tioning. Other portions of liver were frozen in liquid
nitrogen and kept at -70°C for preparation of total
RNA. Blood was collected and serum separated to
evaluate alanine aminotransferases (ALT) and aspartate
aminotransferase (AST) activity [20].
Histological examination
In all experimental groups, 4-μm-thick sections of for-
malin
-fixed and paraffin-embedded livers were routinely
processed for hematoxylin and eosin staining to deter-
mine the extent of liver necrosis/degeneration develop-
ment. Several fields in each slide were randomly
selected, and representative results from 10 animals are
shown.
Immunohistochemistry
Tissue samples from liver were embedded in paraffin
wax and cut into 4-μm serial sections. After being
deparaffinized with xylene, tissue sections were rehy-
drated. Endogenous peroxidase activity was quenched
with 0.6% hydrogen peroxide for 8 minutes at room
temperature. Tissues were then digested with pepsin
(Biogenex, San Ramon, CA, USA) for 10 minutes at
room temperature and washed in phosphate-buffered
saline (PBS). After blocking, slides were incubated for
3 0m i n u t e sa t3 7 ° Cw i t hr a b b i ta n t i - h u m a nc y t o k e r a t i n
monoclonal antibody (BACHEM, Bubendorf, Switzer-
land) or rabbit anti-human albumin antibody (DAKO,
Glostrup, Denmark). Incubation with secondary biotiny-
lated goat anti-rabbit antibody (Vector Laboratories,
Burlingame, CA, USA) was performed after being
washed, followed by incubation with avidin-biotin com-
plex for 30 minutes at room temperature. Diaminioben-
zidene (DAB; Sigma) was used as the visualizing agent.
Sections were counterstained with hematoxylin.
Immunofluorescent staining and fluorescent in situ
hybridization (FISH)
The slides of 4-μm frozen liver sections were deparaffi-
nized in xylene (two times) for 10 minutes, rehydrated,
blocked with 5% donkey serum for 10 minutes, then
incubated for 1 hour with diluted rabbit anti-human
ALB antibody (DAKO) or rabbit anti-human cytokeratin
antibody (BACHEM) at room temperature. Samples
were washed thoroughly with PBS, incubated for 30
minutes at room temperature with donkey anti-rabbit
IgG congujated with PE (Jackson ImmunoResearch,
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slides were blocked again with a 5% normal rabbit
serum for 10 minutes and then localized with diluted
monoclonal Cy5-conjugated anti-human CD45 IgG1
antibody (BD Biosciences Pharmingen, San Diego, CA,
USA) for 1 hour at room temperature. After these pro-
cedures, Y-FISH analysis was performed as follows. The
slides were washed in PBS for 5 minutes, digested at 37°
C with 100 μg/ml RNase A for 30 minutes and then
with 0.005% pepsin solution (pH 2.0) for 5 minutes.
Human Y-chromosome DNA probe labeled with FITC
(CEP Y Spectrum Green, Vysis; Downers Grove, IL,
USA) was used according to the manufacturer’s instruc-
tions. After these, the slides were observed field by field
using confocal fluorescence microscopy (Confocal 1024
microscope; Olympus AX70, Olympus Optical Co. Ltd.).
We screened 40 serial sections of each mouse liver for
positive human cells to determine the number of differ-
entiated cells. A minimum of 100 high-power fields in
tissues from transplanted animals were analyzed.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
analysis
Total RNA was prepared with TRIzol Reagent (Invitro-
gen, Carlsbad, CA, USA) according to the manufac-
turer’s protocol (Gibco Life Technologies, Paisley, UK).
Normal human liver tissue obtained from normal areas
during the surgical resection of hepatocellular carcinoma
was used as a positive control. RNA was purified to
remove contaminating DNA according to the DNA-free
protocol (Ambion, Austin, TX) and quantified using a
spectrophotometer. Equal amounts of RNA were used
for the synthesis of cDNA. Oligonucleotide primers
were human albumin (ALB, 380 bp), forward, 5′-AGC
GGC ACA GCA CTT CTC TCT AGA-3′,r e v e r s e ,
5′-TCC ACA CGG AAT GCT GCC ATG G-3′;h u m a n
cytokeratin 19 (CK19, 328 bp), forward, 5′-ATG GCC
GAG CAG AAC CGG AA-3′, reverse, 5′-CCA TGA
GCC GCT GGT ACT CC-3′; human glutamine synthe-
tase (GS, 397 bp), forward, 5′-GTC AAG ATT GCG
GGG ACT AA-3′, reverse, 5′-TAC GAT TGG CTA
CAC CAC CA-3′;h u m a nb-actin (256 bp), forward, 5′-
GGG TCG GAA GGA TTC CTA-3′, reverse, 5′-GGT
CTC AAA CAT GAT CTG GG-3′;m o u s eg l y c e r a l d e -
hyde 3-phosphate dehydrogenase (GAPDH) (287 bp),
forward, 5′-TCC TGC ACC ACC AAC TGC TTA G-3′,
reverse, 5′-CAG ATC CAC AAC GGA TAC ATT G-3′.
The PCR procedure consisted of 30 cycles of denatura-
tion for 60 s at 94°C, annealing for 60 s at 58°C (ALB
and CK19) or 60°C (GS), and extension for 90 s at 72°C.
The samples were subjected to 35 cycles, and the PCR
products were analyzed on an ethidium bromide-stained
agarose gel.
Western blotting
Mouse sera were subjected to electrophoresis with 0.1%
sodium dodecyl sulfate-7.5% polyacrylamide gel electro-
phoresis gel. Separated proteins were transferred to a
nitrocellulose membrane (Amersham Pharmacia Bio-
tech, Uppsala, Sweden). Human ALB protein was
detected by immunoblotting using monoclonal antibody
against human ALB (clone 4761; Institute of Immunol-
ogy, Tokyo, Japan) diluted with 0.05% Triton X-100 in
Tris-buffered saline containing 1% gelatin, followed by
incubation with a goat anti-rabbit horseradish peroxi-
dase-conjugated antibody (1:10,000 dilution) (E.I. du
Pont de Nemours, Boston, MA, USA). All membranes
were immunoblotted for the mouse GAPDH antibody
(Santa Cruz Biotechnologies Inc., Camarillo, CA, USA)
as the internal standard protein. Immunodetection using
the enhanced chemiluminescence method (ECL kit;
Amersham, Piscataway, NJ, USA) was performed
according to the manufacturer’s instructions. Normal
human and nontransplanted murine sera were used as
controls.
Statistical analysis
To assess the statistical significance of intergroup dif-
ferences in quantitative data, the Mann-Whitney U
test was used to compare mean values between the
two groups. P < 0.01 was considered statistically
significant.
Results
G-CSF-mobilized CD34
+ HSCs ameliorate radiation-
induced liver injury
The initial challenge to study G-CSF-mobilized CD34
+
cells to hepatocyte differentiation was to establish a
model of acute liver damage in immunodeficient mice,
in which the control mice that did not undergo trans-
plantation would recover from the injury. Hepatic
injury in NOD/SCID mice by several different doses of
radiation was studied first. All mice could tolerate up
to 260 cGy. On day 7 after irradiation, the extent of
liver degeneration/necrosis was obvious in all experi-
mental mice, but without significant differences among
G1 and G2 mice (Figure 1d). On day 21, however,
areas of liver degeneration/necrosis were smaller in G1
mice than in G2 mice (Figures 1g and 1h). In addition,
to assess the liver damage induced by irradiation, the
level of ALT and AST activity was measured. In G1
and G2 mice, the activity of serum ALT and AST
showed initially significantly elevated and gradually
decreased with time, and in the G1 mice, both ALT
and AST presented significantly lower values when
compared with the values found in G2 mice at the
same time points (Table 1).
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Page 3 of 8Figure 1 Improved morphology after liver irradiation with or without transplantation of mobilized CD34
+ hematopoietic stem cells
(HSCs). Representative photomicrographs of the liver at 7 or 21 days after irradiation in (a) Group 1 (G1), (b) Group 2 (G2), and (c) Group 3 (G3)
mice. (d) Seven days after irradiation, the extent of liver degeneration/necrosis (arrow) was not significantly different between (e) G1 and (f) G2
mice. Twenty-one days after irradiation, however, areas of liver degeneration/necrosis were smaller in (g) G1 mice compared with those in (h)
G2 mice. Paraffin-embedded sections were processed for hematoxylin and eosin staining. Original magnification, ×20.
Table 1 Effect of G-CSF-mobilized CD34
+ cells on murine liver function after irradiation
Mice ALT (IU/L) AST (IU/L) ALB
+/Y-chromosome
+ cells
0d 3d 7d 2 1d 0d 3d 7d 2 1d 1 4d 2 1d
G1 37.9 ± 7.2 418.3 ± 49.8
† 228.3 ± 32.7* 78.3 ± 5.7* 31.1 ± 6.9 398.3 ± 42.8
† 256.3 ± 36.8* 89.2 ± 6.4* _ +
#
G2 36.4 ± 6.7 434.5 ± 53.8 378.6 ± 51.2 169.3 ± 34.7 29.8 ± 6.3 402.5 ± 46.5 381.2 ± 50.9 209.5 ± 38.4 _ _
G3 38.4 ± 7.1 40.9 ± 6.1 38.3 ± 6.8 42.3 ± 6.7 30.7 ± 6.5 31.7 ± 6.4 30.8 ± 6.9 31.1 ± 6.5 _ _
Data are means ± SD (n = 10). *P < 0.05 compared with the G2 mice; †P > 0.05 compared with the G2 mice. #Human ALB
+/Y chromosome
+ hepatocyte-like cells
in the liver of G1 mice. G-CSF, granulocyte colony-stimulating factor; ALB, albumin; ALT, alanine aminotransferase aspartate; AST, aspartate aminotransferase.
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+ HSCs engraft into irradiated mice
and differentiate
Considering the possible continued existence of donor-
derived hematopoietic cells in recipient mice, we used
triple-color immunofluorescence to discriminate
between donor-derived epithelial and donor-derived
haematopoietic cells in the same tissue sections. In the
liver of G1 mice killed 21 days after irradiation, human
ALB (Figure 2A), CK19 (Figure 2B) positive hepatocytes,
both human ALB and human Y-chromosome positive
hepatocytes (Figure 2C), or both human CK19 and
human Y-chromosome positive hepatocyte-like cells
(Figure 2D) formed cords of hepatocytes occupying
~30% of a given 4-μm section surrounding portal tracts
in a pattern similar to that seen in hepatic regeneration
from hepatic oval cells [21,22], but this phenomenon
was not found in Groups 2 and 3 mice (data not
shown). These results indicate that G-CSF-mobilized
CD34
+ HSCs might be capable of differentiating into
ALB-producing cells in the liver of irradiated recipients.
To evaluate the function of these repopulating cells,
we analyzed the production of ALB in donor-derived
parenchymal cells. As shown in Figure 2E, we detected
human ALB protein in the sera of the G1 mice on day
21 after irradiation. The immunoreactive band of con-
trol human serum diluted 1:100 was 103 times stronger
than the faint band of nondiluted serum from the non-
transplanted control mice (G2 and G3 mice). Since the
concentration of ALB in the nontransplanted control
mice serum of the same band scarcely changes, the
strong immunoreactive bands of sera from G1 mice
i n d i c a t et h ep r e s e n c eo fh u m a nA L B .T h e s eo b s e r v a -
t i o n sp r o v e dt h a tt r a n s p l a n t e dG - C S F - m o b i l i z e dC D 3 4
+
HSCs developed into functional hepatocytes.
Mice were killed 7 or 21 days after transplantation
with G-CSF-mobilized CD34
+ HSCs. RNA samples were
obtained from the livers of the mice in each group. RT-
PCR was performed to detect human-specific expression
of ALB, GS, and CK-19. To demonstrate the specificity
of the primers to detect human ALB, GS, and CK19
mRNA, we examined the mRNA in nontransplanted
mice livers (G2) and in normal control mice livers (G3).
These samples were negative in every assay, and an
example is shown in Figure 3. Because of the phenom-
enon known as “stem cell priming,” in which primitive
hematopoietic cells have been shown to express low
levels of various mRNA before committing to a particu-
lar blood cell lineage [23,24], we also tested the G-CSF-
mobilized CD34
+ HSCs for ALB, GS, and CK19 expres-
sion. As shown in Figure 3, the starting CD34
+ HSCs
did not express ALB, GS, or CK19 when they were
freshly isolated. However, in the mice (G1) with radia-
tion-mediated liver injury that received CD34
+ HSCs
transplantation 21 days later, RT-PCR analysis showed
that human GS, CK19 and ALB mRNA were expressed
(Figure 3), which meant a portion of the transplanted
human stem cells had localized to the liver and had
begun to express human ALB when analyzed 21 days
after the liver damage.
Discussion
The plasticity studies reported so far in the literature
have demonstrated that HSCs can differentiate to tissues
other than blood [4-19]. In recent clinical practice, cir-
culating HSCs numbers can be increased by mobiliza-
tion from the bone marrow with G-CSF [25,26], and the
mobilization of HSCs by G-CSF has been shown to be
involved in the reparation of the infarcted heart [8,27].
Therefore, we decided to address whether G-CSF-
mobilized HSCs could contribute to faster recovery and
promote the regeneration process after acute liver injury
by radiation. The present study provides the first evi-
dence that mobilization of G-CSF-mobilized CD34
+
HSCs after liver irradiation has beneficial effects in pre-
venting and/or reducing radiation-induced damage. In
our acute radiation-induced liver injury model, G-CSF-
mobilized CD34
+ HSC administration ameliorated the
histological damage and accelerated the regeneration
process. In all animals sacrificed 21 days posttransplan-
tation, immunohistochemical analysis showed human
ALB/cytokeratin-positive cells in mobilized CD34
+ HSC-
treated mouse liver. FISH analysis using the human Y
chromosome also showed positive signals. In contrast,
immunopositive cells were not detected in the irradiated
control group. Furthermore, human-specific ALB
mRNA was expressed in the liver, and human ALB was
detected in the serum only in the mobilized CD34
+
HSCs-treated mice. These observations prove that trans-
planted G-CSF-mobilized CD34
+ HSCs might develop
into functional hepatocytes.
Recently, cell fusion was suggested as an explanation
for stem cell plasticity. Some scholars raise doubts about
whether transdifferentiation or dedifferentiation actually
occurs [28-30]. Their findings in vitro or in vivo sug-
gested that stem cell “transdifferentiation” or “plasticity”
is a result of cell fusion events. In this study, we did not
determine whether fusion of G-CSF-mobilized CD34
+
HSCs with liver cells was responsible for their hepato-
cyte-like morphology or whether the cells change their
fate in vivo in response to local cues after transplantation.
So the question remains as to what is the role of G-
CSF-mobilized HSCs in the regeneration of radiation-
induced liver injury and what is the regenerative
process. Recently, Yannaki et al. [31] indicated that
treatment with G-CSF-mobilized HSCs significantly
improved survival and liver histology in chemically
injured mice, predominantly by promoting endogenous
repair mechanisms. Similar regenerative processes have
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Page 5 of 8Figure 2 Engraftment and in vivo differentiation of granulocyte colony-stimulating factor (G-CSF)-mobilized CD34
+ HSCs into
hepatocyte-like cells in G1 mice 21 days after irradiation and transplantation. Deparaffinized section of liver was stained with (a) anti-
human albumin (ALB) antibody or (b) anti-human cytokeratin antibody. (c) Liver was stained with anti-human ALB antibody (red), anti-human
CD45 antibody (blue), and human Y chromosome DNA probe (green). (d) Liver was stained with anti-human cytokeratin antibody (red), anti-
human CD45 antibody (blue), and human Y chromosome DNA probe (green). The arrow indicates Y chromosome
+cytokeratin
+ or Y
chromosome
+ALB
+ cells in the liver of G1 mice. The absence of chromosomal staining in some ALB
+/cytokeratin
+ cell nuclei may be a result of
partial sampling of nuclei in the 4-μm thin tissue section. (e) Human serum ALB in the plasma of G1 mice was identified by Western blot
analysis. Mouse glyceraldehyde 3-phosphate dehydrogenase (GAPDH) acts as internal standard. Original magnification, (a-d), ×20; inset in (c) and
(d), ×60. Representative images are shown.
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Caenorhabditis elegans.I na d d i t i o n ,b o n em a r r o w -
derived stem cells could initiate pancreatic regeneration
[32]. However, in our study, the percentage of G-CSF-
mobilized CD34
+ HSC-derived hepatocyte-like cells pre-
sent in sections of irradiated hepatic tissues was much
higher than that reported by Yannaki et al.[ 3 1 ] .S ow e
suggest it might be G-CSF-mobilized CD34
+ HSCs that
ameliorate radiation-induced damage to liver by the
ability to generate hepatocytes, although we still could
not exclude the possibility that endogenous hepatic
stem cells are also involved in regenerative processes at
t h es a m et i m e .H o w e v e r ,d e s p i t et h eo b s c u r i t yo ft h e
cellular mechanism, the ability of G-CSF-mobilized
HSCs to reestablish physiological function in the whole
animal has been documented [6,8,18,19,31].
Conclusions
In summary, our data suggest that G-CSF-mobilized
CD34
+ HSCs, given their potential to engraft into liver
tissue and their ability to ameliorate the injurious effects
of radiation, might provide a new approach for the
treatment of some liver diseases. This study indicates a
clinical applicable protocol for the use of HSC mobiliza-
tion to ameliorate radiation-induced damage.
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